M. Cortese

SARS-CoV-2 oral tablet vaccination induces neutralizing mucosal IgA in a phase 1 open label trial

E. Dora, S. Tucker, C. Martínez, 2022, medRxiv.

A New Butyrate Releaser Exerts a Protective Action against SARS-CoV-2 Infection in Human Intestine

M. Capasso, R. Troncone, Pellegrino Cerino, 2022, Molecules.

Protective effects of the postbiotic deriving from cow’s milk fermentation with L. paracasei CBA L74 against Rotavirus infection in human enterocytes

R. Berni Canani, L. Paparo, C. Bruno, 2022, Scientific Reports.